REAL TIME SEGMENTATION METHOD FOR UNDERGROUND TRACK AREA BASED ON IMPROVED STDC



Clinical Response to Gefitinib Retreatment of Lung Adenocarcinoma Patients Who Benefited from An Initial Gefitinib Therapy: A Retrospective Analysis

Background and objective Gefitinib is an epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) that has been widely used for the treatment of non-small cell lung cancer (NSCLC).It is most effective in women, as well as in patients who have never smoked, have pulmonary adenocarcinomas, or are of Asian origin.Several treatment options

read more